Bradley T. King

Array ( [id] => 6214462 [patent_doc_number] => 20110136884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/992535 [patent_app_country] => US [patent_app_date] => 2009-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5755 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136884.pdf [firstpage_image] =>[orig_patent_app_number] => 12992535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5316516 [patent_doc_number] => 20090281114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'INDOLYLALKYL DERIVATIVES OF PYRIMIDINYLPIPERAZINE AND METABOLITES THEREOF FOR TREATMENT OF ANXIETY, DEPRESSION, AND SEXUAL DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 12/437220 [patent_app_country] => US [patent_app_date] => 2009-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24244 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281114.pdf [firstpage_image] =>[orig_patent_app_number] => 12437220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7568007 [patent_doc_number] => 20110288070 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'METHODS FOR TREATING COGNITIVE DISORDERS USING INHIBITORS OF HISTONE DEACETYLASE' [patent_app_type] => utility [patent_app_number] => 12/991095 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 113092 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20110288070.pdf [firstpage_image] =>[orig_patent_app_number] => 12991095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199622 [patent_doc_number] => 20120122966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'USE OF ORGANIC DYES AS ANALGESIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/138878 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5397 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122966.pdf [firstpage_image] =>[orig_patent_app_number] => 13138878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6569091 [patent_doc_number] => 20100234414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'Use of Loratadine 10mg for the prevention of upper respiratory inflammation/sinus infections caused from exposure to bacteria and viruses on airplane flights' [patent_app_type] => utility [patent_app_number] => 12/404296 [patent_app_country] => US [patent_app_date] => 2009-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 269 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234414.pdf [firstpage_image] =>[orig_patent_app_number] => 12404296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7774272 [patent_doc_number] => 08119618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-21 [patent_title] => 'Compositions and methods for the treatment of inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 12/402378 [patent_app_country] => US [patent_app_date] => 2009-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9182 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/119/08119618.pdf [firstpage_image] =>[orig_patent_app_number] => 12402378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055757 [patent_doc_number] => 20110112117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'TREATMENT OF HERPES VIRUS RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 12/921006 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20782 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112117.pdf [firstpage_image] =>[orig_patent_app_number] => 12921006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691947 [patent_doc_number] => 08822542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Isoketal scavengers and mitigation of disorders involving oxidative injury' [patent_app_type] => utility [patent_app_number] => 12/395464 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 52 [patent_no_of_words] => 31047 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12395464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8760156 [patent_doc_number] => 08420677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Use of 3,3′-diindolylmethane' [patent_app_type] => utility [patent_app_number] => 12/918143 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2961 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6539019 [patent_doc_number] => 20100204334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Intranasal Delivery of Modafinil' [patent_app_type] => utility [patent_app_number] => 12/367496 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4525 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204334.pdf [firstpage_image] =>[orig_patent_app_number] => 12367496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564953 [patent_doc_number] => 20090137806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'DUAL NK1/NK3 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/361569 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118089 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137806.pdf [firstpage_image] =>[orig_patent_app_number] => 12361569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392320 [patent_doc_number] => 20090209633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Treatment of Pain With Resiniferatoxin and Related Analogs' [patent_app_type] => utility [patent_app_number] => 12/356469 [patent_app_country] => US [patent_app_date] => 2009-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12124 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209633.pdf [firstpage_image] =>[orig_patent_app_number] => 12356469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279208 [patent_doc_number] => 20090131340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'USE OF FLAVONOIDS AS IMMUNOMODULATING OR IMMUNO-PROTECTIVE AGENTS IN COSMETIC AND DERMATOLOGICAL PREPARATIONS' [patent_app_type] => utility [patent_app_number] => 12/355367 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131340.pdf [firstpage_image] =>[orig_patent_app_number] => 12355367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898127 [patent_doc_number] => 08921342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Liver function-protecting agent' [patent_app_type] => utility [patent_app_number] => 12/811744 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5610 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12811744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5355600 [patent_doc_number] => 20090186944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'PREVENTION AND TREATMENT OF BREAST CANCER WITH 4-HYDROXY TAMOXIFEN' [patent_app_type] => utility [patent_app_number] => 12/353890 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11211 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186944.pdf [firstpage_image] =>[orig_patent_app_number] => 12353890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473130 [patent_doc_number] => 20090246296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL DONORS' [patent_app_type] => utility [patent_app_number] => 12/346694 [patent_app_country] => US [patent_app_date] => 2008-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7349 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246296.pdf [firstpage_image] =>[orig_patent_app_number] => 12346694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436358 [patent_doc_number] => 20090170945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'PREGABALIN SALTS' [patent_app_type] => utility [patent_app_number] => 12/339922 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5023 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170945.pdf [firstpage_image] =>[orig_patent_app_number] => 12339922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5380387 [patent_doc_number] => 20090192226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Materials and Methods for Treatment of Pathological Ocular Vascular Proliferation' [patent_app_type] => utility [patent_app_number] => 12/336814 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7403 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192226.pdf [firstpage_image] =>[orig_patent_app_number] => 12336814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441875 [patent_doc_number] => 20090093514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'IMMUNE RESPONSE MODIFIER FORMULATIONS CONTAINING OLEIC ACID AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/334255 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7232 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093514.pdf [firstpage_image] =>[orig_patent_app_number] => 12334255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502873 [patent_doc_number] => 20090163561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'AMORPHOUS METAXALONE AND AMORPHOUS DISPERSIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/332795 [patent_app_country] => US [patent_app_date] => 2008-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 12979 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163561.pdf [firstpage_image] =>[orig_patent_app_number] => 12332795 [rel_patent_id] =>[rel_patent_doc_number] =>)